Paul F Glidden

This inventor holds 8 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent. Top assignees: Biovascular, Inc., Zogenix Mds, Inc., Other. Active years: 2010-2023.

USPTO Granted Patents = 8 (Patent Applications = 4)

% Patents Active = 37.5

CIPO Patents = 1

Average Co-Inventor Count = 1.5

ph-index = 4

Forward Citations = 31(Granted Patents)

Company Filing History:

2 out of 834,411

Other

patents

Years Active: 2010-2023

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11649259 - Polymorphic forms of deoxycytidine, compositions comprising the same and uses (2023-05-16),

2. 9962443 - Cellular activity targeted nanoparticle system and methods of producing the nanoparticle system (2018-05-08),

3. 9750698 - Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor (2017-09-05),

4. 9381198 - Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor (2016-07-05),

5. 9040483 - Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor (2015-05-26),

6. 8282921 - tRNA synthetase fragments (2012-10-09),

7. 8188034 - Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation (2012-05-29),

8. 7691839 - Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation (2010-04-06),

Title: A Profile on Inventor Paul F. Glidden

Introduction

Paul F. Glidden is a distinguished inventor based in San Diego, California. With a remarkable portfolio of eight patents, Glidden has made significant contributions to the fields of biotechnology and pharmaceuticals.

Latest Patents

Among his latest innovations, Glidden has developed methods related to polymorphic forms of deoxycytidine. These patents detail not only the polymorphic forms of deoxycytidine but also compositions that include these forms and their applications in treating mitochondrial diseases. Another notable patent involves a cellular activity targeted nanoparticle system designed for specific cellular interactions. This system is configured to deliver treatments via electromagnetic radiation within a specific range, highlighting Glidden's innovative approach to medical technology.

Career Highlights

Throughout his career, Paul F. Glidden has been associated with notable companies, including Biovascular, Inc. His work in these organizations has contributed to advancements in patentable technologies that address critical health issues.

Collaborations

In his professional journey, Glidden has collaborated with distinguished individuals such as Alison J. Pilgrim and Stephen R. Hanson. Their combined efforts have played a role in enhancing the impact of his inventions.

Conclusion

Paul F. Glidden stands out as a pivotal figure in the realm of inventions, particularly in biotechnology. His dedication to innovation continues to drive advancements that hold promise for improving medical treatments and patient care.